NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2013 | Mar2012 | |
---|---|---|---|---|---|
Adjusted EPS | ₹18.43 | ₹-35.46 | ₹7.34 | ₹5.75 | ₹5.75 |
What is the latest Earnings Per Share (EPS) of NATH BIOGENES (INDIA) ?
Year | Earnings Per Share (EPS) |
---|---|
Mar2024 | ₹18.43 |
Mar2023 | ₹-35.46 |
Mar2022 | ₹7.34 |
Mar2013 | ₹5.75 |
Mar2012 | ₹5.75 |
How is Earnings Per Share (EPS) of NATH BIOGENES (INDIA) Trending?
Years | Earnings Per Share (EPS) | % Change | |
---|---|---|---|
Mar2024 | ₹18.43 | Positive | |
Mar2023 | ₹-35.46 | Negative | |
Mar2022 | ₹7.34 | 27.65 | |
Mar2013 | ₹5.75 | 0.00 | |
Mar2012 | ₹5.75 | - |
Compare Earnings Per Share (EPS) of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹392.7 Cr | 1.5% | 9.3% | -0.2% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,657.2 Cr | -2.5% | 0.1% | 17.5% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,685.8 Cr | -7.2% | -2.8% | 41% | Stock Analytics | |
VENKYS (INDIA) | ₹2,285.5 Cr | -1.3% | -0.5% | -13.1% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,475.9 Cr | -0.8% | -2.7% | -29.7% | Stock Analytics | |
INDO US BIOTECH | ₹302.3 Cr | -10.2% | -0.5% | -28% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | 1.5% |
9.3% |
-0.2% |
SENSEX | -1% |
-0.9% |
6.7% |
You may also like the below Video Courses